BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7426385)

  • 21. Coordination of microtubules and the actin cytoskeleton is important in osteoclast function, but calcitonin disrupts sealing zones without affecting microtubule networks.
    Okumura S; Mizoguchi T; Sato N; Yamaki M; Kobayashi Y; Yamauchi H; Ozawa H; Udagawa N; Takahashi N
    Bone; 2006 Oct; 39(4):684-93. PubMed ID: 16774853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone.
    Flanagan AM; Chambers TJ
    Bone Miner; 1989 Apr; 6(1):33-43. PubMed ID: 2526673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of bone resorption by colchicine in organ culture.
    Raisz LG; Holtrop ME; Simmons HA
    Endocrinology; 1973 Feb; 92(2):556-62. PubMed ID: 4682867
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction of dichloromethylene diphosphonate and vitamin D on bone of thyroparathyroidectomized rats.
    Weisbrode SE; Capen CC; Pendley CB
    Am J Pathol; 1977 Oct; 89(1):137-52. PubMed ID: 143891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
    Väänänen K
    Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystatin C, and inhibitor of bone resorption produced by osteoblasts.
    Lerner UH; Johansson L; Ranjsö M; Rosenquist JB; Reinholt FP; Grubb A
    Acta Physiol Scand; 1997 Sep; 161(1):81-92. PubMed ID: 9381954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.
    Sato M; Grasser W; Endo N; Akins R; Simmons H; Thompson DD; Golub E; Rodan GA
    J Clin Invest; 1991 Dec; 88(6):2095-105. PubMed ID: 1661297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of parathyroid hormone, dibutyryl cyclic AMP, calcitonin and colchicine on glucosamine incorporation into bone cells.
    Severson AR
    Cell Mol Biol; 1985; 31(4):251-7. PubMed ID: 2992786
    [No Abstract]   [Full Text] [Related]  

  • 29. DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones.
    Lorenzo JA; Raisz LG; Hock JM
    J Clin Invest; 1983 Dec; 72(6):1924-9. PubMed ID: 6643680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors.
    Amano S; Hanazawa S; Kawata Y; Ohta K; Kitami H; Kitano S
    J Bone Miner Res; 1992 Mar; 7(3):321-8. PubMed ID: 1585834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells.
    Sugawara K; Hamada M; Hosoi S; Tamaoki T
    Anal Biochem; 1998 Jan; 255(2):204-10. PubMed ID: 9451505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S 12911-2 inhibits osteoclastic bone resorption in vitro.
    Takahashi N; Sasaki T; Tsouderos Y; Suda T
    J Bone Miner Res; 2003 Jun; 18(6):1082-7. PubMed ID: 12817762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon gamma and calcitonin induce differential changes in cellular kinetics and morphology of osteoclasts in cultured neonatal mouse calvaria.
    Klaushofer K; Hörandner H; Hoffmann O; Czerwenka E; König U; Koller K; Peterlik M
    J Bone Miner Res; 1989 Aug; 4(4):585-606. PubMed ID: 2510468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone resorption by isolated human osteoclasts in vitro: effects of calcitonin.
    Murrills RJ; Shane E; Lindsay R; Dempster DW
    J Bone Miner Res; 1989 Apr; 4(2):259-68. PubMed ID: 2728929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of peptides from the calcitonin genes on bone and bone cells.
    Zaidi M; Chambers TJ; Bevis PJ; Beacham JL; Gaines Das RE; MacIntyre I
    Q J Exp Physiol; 1988 Jul; 73(4):471-85. PubMed ID: 2845462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dichloromethylene diphosphonate (Cl2-MDP) on bone resorption induced by PHA-stimulated human mononuclear cells in organ culture.
    Holak HM; Szymaniec S; Skriabin A
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):77-83. PubMed ID: 6236769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of dichloromethylene diphosphonate on bone metabolism in calcium and phosphorus-depleted rats.
    Evans RA; Wergedal JE; Baylink DJ
    Miner Electrolyte Metab; 1983; 9(3):119-24. PubMed ID: 6224075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of phosphate on calcium release, lysosomal enzyme activity in the medium, and osteoclast morphometry in cultured fetal rat bones.
    Lorenzo JA; Holtrop ME; Raisz LG
    Metab Bone Dis Relat Res; 1984; 5(4):187-90. PubMed ID: 6738356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roentgenologic and histologic changes in bone produced by thyrocalcitonin.
    Foster GV; Doyle FH; Bordier P; Matrajt H; Tun-Chot S
    Am J Med; 1967 Nov; 43(5):691-5. PubMed ID: 6054838
    [No Abstract]   [Full Text] [Related]  

  • 40. Calcitonin-like effects of forskolin and choleratoxin on surface area and motility of isolated rabbit osteoclasts.
    Ransjö M; Lerner UH; Heersche JN
    J Bone Miner Res; 1988 Dec; 3(6):611-9. PubMed ID: 3251398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.